AIM-HI announces the 2024 Women’s Venture Competition’s first prize winner

AIM-HI Accelerator Fund shared a post on LinkedIn:

“AIM-HI is pleased to announce that the 2024 Women’s Venture Competition’s first prize winner with distinction goes to HDAX Therapeutics led by its CEO and Co-Founder, Nabanita Nawar and the Second Prize Winner goes to ARMA BIO, led by Co-Founder and CSO, Paraskevi (Evi) Giannakakou.

Congratulations!

‘HDAX was purpose-built to address the challenges of developing effective drugs targeting HDAC6, for diseases such as chemotherapy-induced peripheral neuropathies (CIPN). To have this honor to be the First Prize winner with Distinction of the 2024 AIM-HI Women’s Venture Competition is a defining moment for myself, and the entire team at HDAX. We have a vision that is starting to become a reality for cancer patients. Being recognized by AIM-HI and its impressive committees gives all of us at HDAX the boost we needed to continue and double down in our fight for patients as we move closer to bringing our therapies to market,’ says Dr. Nabanita Nawar.

‘The Women’s Venture Competition’s goal of bolstering women-led startups at the forefront of life-saving innovations through strategic partnerships and empowering these enterprises with access to our global network of influential thought leaders is what drives AIM-HI to recognize and award these women-led oncology startups to continue their vital work in our collective effort to beat cancer,’ says Sujuan Ba, Ph.D., Co-founder and CEO of AIM-HI.

The winners will be honored on October 18 at the 2024 Global Summit and Award Ceremonies for Cancer Research & Entrepreneurship.

Register here.

The 2024 Women’s Venture Competition committees are comprised of the following persons:
Anna D. Barker, 
Webster Cavenee, 
Aleksandra Filipovic 
Pamela Garzone, 
Dimitra Georganopoulou,
Gary Gordon, 
Daniel Johnson, 
Raju Kucherlapati, 
Matthew Lawler
Brian R. Leyland-Jones BSc (1st Class Hons) 
Scott Lippman, 
Jimmy Lu, 
Eva Martin, 
Kornelia Polyak, 
Michael Salgaller, 
Libia F. Scheller, 
Fei Shen, 
Matt Tremblay.

Previous Women’s Venture Competition First Prize Winners Include:
2023 – March Biosciences, Sarah Hein, Ph.D., CEO
2022 – RiverWalk Therapeutics, Inc., Johanna Vincze Webb, President & CEO
2021 – Ardan Pharma, María Varela, CEO
2020 – Privo Technologies Inc, Manijeh Goldberg, PhD, CEO.”

Read further.
Source: AIM-HI Accelerator Fund/LinkedIn